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Abstract
BACKGROUND: Ischemia–reperfusion injury (IRI) is 
a common phenomenon occurring during liver surgery, 
transplantation, and trauma. IRI causes oxidative stress 
which plays a critical role in causing organ damage. The 
Nrf2 is the master regulator of numerous genes, encoding 
antioxidant, detoxifying, and cytoprotective molecules. 
Nrf2 dysfunction has been implicated in the pathogenesis 
of several inflammatory disorders, cancer, and aging. This 
study was undertaken to investigate the effect of Nrf2 
pathway activator (dh404) on warm liver IRI in a rodent 
model.
METHODS: Ten Sprague-Dawley rats were treated 
with dh404 or vehicle. Dh404 was dissolved in sesame 
oil and was given orally (1.5mg/kg) the night before and 
5 hours before procedures. Rat livers were subjected 
to 60 minutes of 70% ischemia followed by 3 hours of 
reperfusion. Serum ALT and Malondialdehyde (MDA) 
were determined and liver tissue was processed for 
histological examination, and determination of apoptosis, 
myeloperoxidase (MPO) activity, ADP/ATP ratio, and 
expressions of Nrf2, eNOS, anti-oxidant enzymes, and 
inflammatory mediators. 
RESULTS: Serum ALT and MDA levels and tissue 
MPO activity were significantly lower, expression of 
the anti-oxidant enzyme, glutamate cysteine ligase was 
significantly higher, whereas expression of NFkB and 
COX-2 was unchanged in the dh404-treated group. 
Although the total Suzuki histology score did not 
differ significantly, the extent of sinusoidal congestion, 
vacuolization, and apoptosis was significantly reduced 
in the dh404 treated compared to the untreated group 
(P<0.01). 
CONCLUSION: Pre-treatment with dh404 resulted in 
partial attenuation of hepatic ischemia reperfusion injury 
in rats. 
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INTRODUCTION
Liver Ischemia Reperfusion Injury (IRI) is a major 
contributor to tissue damage during liver transplantation, 
liver resection procedures, hypovolemic shock, and 
trauma. IRI is a major cause of primary non-function after 
liver transplantation and occurs when the blood supply 
is restored in the ischemic tissues[1-3]. Clamping of the 
hepatic artery and portal vein is a common procedure 
in liver transplantation. This leads to disruption of the 
cellular mitochondrial oxidative phosphorylation and 
accumulation of metabolic intermediates during the 
ischemic period and oxidative stress following the 
resumption of blood flow. The resulting oxidative stress 
results in cellular damage and release of chemotactic 
factors which amplify the inflammatory response 
during reperfusion[4-5].  Moreover oxidative stress 
impairs mitochondrial function which leads to further 
production ROS and amplification of oxidative stress 
and tissue injury[6].  A major source of inflammation 
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and ROS production in the early phase of reperfusion 
is Kpuffer cells, which release inflammatory mediators, 
such as TNF-α and IL-1. Release of these cytokines and 
chemokines, in turn, triggers activation of neutrophils 
and their infiltration in the liver tissue[4].  Together these 
events result in oxidative and inflammatory stress in the 
liver tissue. 
Nuclear factor erythroid 2-related factor 2 (Nrf2) 
is a transcription factor, which is widely expressed 
in many organs[5-8]. It regulates expression of genes 
encoding antioxidant and phase II enzyme, including 
glutathione peroxidase (GPx), γ-glutamate-cysteine 
ligase catalytic (GCLC) and modifier (GCLM) subunit, 
catalase (CAT), NAD(P)H: quinone oxidoreductase 1 
(NQO1), and heme oxygenase 1 (HO-1), by binding to 
the antioxidant response element (ARE) in the promoters 
segments of the corresponding genes. Therefore, Nrf2 
plays a central role in cellular redox system. Natural 
Nrf2 activators have been used for centuries as Chinese 
herbal medications for the treatment of a number of 
inflammatory conditions[9]. Recently, Ke  et al. (2013)
reported that Nrf2 has a protective role against ischemia-
induced hepatocellular damage using Nrf2 deficient 
mouse liver transplants[10].
The aim of the present study was to test the hypothesis 
that pre-treatment with a potent, synthetic Nrf2 activator, 
dh404, (CDDO-9,11-dihydro-trifluoroethyl amide 
[CDDO-dhTFEA]) may attenuate severity of liver IRI in a 
rodent model through upregulation of cellular antioxidant 
and anti-inflammatory machinery. 
METHODS
Animals
All procedures were approved by the Institutional Animal 
Care and Use Committee (University of California, 
Irvine). Male Sprague-Dawley rats (200-250 g) were 
purchased from Charles River (Wilmington, MA). The 
animals were housed in the animal care facility for 
acclimatization prior to the study. Animals were allowed 
free access to food and water, and were maintained on a 
12 hour light–dark cycle. They were fasted 12 h prior to 
the start of the experiments. Dh404 was provided by Reata 
Pharmaceuticals, Inc. (Irving, TX). The chemical name 
for dh404 is CDDO-9,11-dihydro-trifluoroethyl amide 
(CDDO-dhTFEA) (11). 
Experimental Design
The rats were randomly divided into 2 experimental 
groups: (1) Control group (n=9): Were subjected to 1 hour 
of ischemia followed by 3 hours of reperfusion. (2) Dh404 
group (n=8) received dh404 (1.5 mg /kg, twice/day) by 
oral gavage the night before and 5 hours prior to surgery. 
Dh404 was dissolved in sesame oil and given. The rats in 
the control group were given sesame oil alone.
Operative Procedure
Under general isoflurane anesthesia, a midline incision 
was made. The left and median portal triad was occluded 
by a micro vascular clamp to achieve 70% hepatic 
ischemia[12-14]. After 1 hour, the clamp was removed and 
the abdominal wall was closed. Three hours later after 
declamping, blood samples and liver specimens were 
collected under the general anesthesia for analysis.
HISTOLOGIC ANALYSIS
Liver tissue specimens were fixed with 10% natural 
buffered formalin and embedded in paraffin. The 5 
micrometers sections were made and stained with 
hematoxylin and eosin. The severity of I/RI was graded 
blindly using modified Suzuki’s criteria[15]. In this 
classification, sinusoidal congestion, hepatocyte necrosis 
and ballooning degeneration are graded on a scale of 
0–4. No necrosis, congestion, or centrilobular ballooning 
is given a score of 0, whereas severe congestion/
ballooning, and >60% lobular necrosis is given a value 
of 4.
Assessment of Apoptosis in Liver
A p o p t o s i s  w a s  d e t e r m i n e d  b y  t h e  t e r m i n a l 
deoxynucleotidyltransferase (TdT)-mediated dUTP 
nick-end labelling (TUNEL) technique (ApopTag Plus 
Peroxidase In Situ Apoptosis Fluorescein Detection Kit, 
Millipore, MA). Total 20 random fields were examined 
by confocal microscopy (x20 objective) for each section. 
An apoptotic index (the number of nuclei labeled by 
the TUNEL method/the number of total nuclei) was 
calculated[16].
M e a s u r e m e n t  o f  S e r u m  A l a n i n e 
A m i n o t r a n s f e r a s e  ( A L T )  a n d 
Malondialdehyde (MDA)
Blood samples were obtained from the right heart 
ventricle. Serum ALT level was determined to assess 
the liver injury by using commercial kits (Bio Vision, 
CA) according to the manufacturer’s instructions. Serum 
MDA formation assay was performed using the TBARS 
assay kit (Cayman, USA) according to the manufacturer’s 
instructions. 
Measurement of Liver Myeloperoxidase 
(MPO) 
The presence of MPO was used as an index of neutrophil 
accumulation in the liver   using the MPO colorimetric 
Assay Kit (BioVision, Milpitas, CA) according to the 
manufacturer’s instructions[17].  
Western Blotting Analysis
The protein was extracted with CelLytic™ NuCLEAR™ 
Extraction Kit (Sigma) following the manufacturer’s 
instruction. The Bio-Rad DC Protein Assay (Bio-Rad 
Laboratories, Hercules, CA) was used to determine 
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protein concentration. Target proteins were measured 
by Western blot analysis with the following antibodies: 
rabbit antibodies against Nrf2 (1:200 dilution, Abcam), 
GCLM (1:1,000 dilution, Abcam), GCLC (1:800 
dilution, Abcam), and GAPDH (1:5,000 dilution, 
Sigma). Aliquots containing 50 μg proteins were heated 
for 5 min at 55°C and were loaded on NuPAGE 4%-
12% Bis-Tris gel (Life Technologies, Grand Island, NY), 
and then transferred to a PVDF membrane (Pall Life 
Sciences, Ann Arbor, MI). The membrane was blocked 
in TBS-T (Thermo) containing 5% blocking grade non-
fat dry milk (Bio-Rad), and incubated overnight with 
primary antibodies at 4°C. After washing, the membrane 
was incubated with HRP-conjugated goat anti-rabbit 
secondary antibody (Cell signals) at 1:3,000 dilution at 
RT for 2 hours. Immunoreactive bands were visualized 
using an enhanced chemiluminescence detection system 
(Thermo Scientific, Rockford, IL)[8]. Densitometric 
measurements were done with Image Quant (Molecular 
Dynamics). GAPDH bands, as a housekeeping protein, 
were used to normalize the expression of the target 
proteins.
Statistical Analysis
All results were presented as mean ± standard deviation 
(SD). Comparisons between the two experimental groups 
were performed with Student’s t-test, Mann–Whitney’s 
U test t, as appropriate using Stat View-J 5.0 software. 
Statistical significance was defined as p-value less than 
0.05.
RESULT
Liver Damage Evaluation by Histological 
Assay 
H&E staining was used to determine sinusoidal 
congestion, vacuolization, and focal necrosis (Figure 1A). 
Scores were given using the Suzuki model (Figure 1B). 
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dh404 
Fig.1 
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Figure 1
Liver Damage Evaluation by Histological Assay 
Note. (A) Liver tissue specimens were stained with hematoxylin and eosin. Representative specimens are shown (x40 - 
x200). (B) Suzuki score The level of sinusoidal congestion and vacuolization in the dh404 treated group was significantly 
improved compared to the untreated group but not necrosis level. There was no significant difference in the total score. 
Data represent mean±S.D.
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TUNEL Staining in Liver Post Ischemia/Reperfusion Injury 
Note.(A). a-d. TUNEL staining in the control group (a; DAPI ×63, b; TUNEL×63, c; Merged×63, d; Merged ×20). e-h. 
Dh404 group. (Arrows indicate apoptotic cells) Apoptotic index indicates that the dh404 treated group had significantly 
less TUNEL-positive cells when compared to the control group (P<0.05). (B). Apoptotic index. Data represent mean±S.D.
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Figure 3
Biochemical Makers for Liver Damage 
Note.The levels of serum ALT (A), MDA (B) and MPO(C) in the liver tissue were determined. All of them in the dh404 
treated group showed significantly lower compared to the control group. However, there was no significant difference in 
ADP/ATP ratio (D).
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The level of congestion and vacuolization in the dh404 
treated group was significantly improved compared to 
the control group (congestion: 2.2 ±1.1 v.s. 3.2 ±1.3; 
vacuolization 2.6 ±1.3 v.s.3.7 ±0.5, respectively, P<0.05) 
However, there was no significant difference in total score 
between the control and dh404 treated group (8.7 ±2.7 v.s. 
6.9±3.4, N.S.).
Assessment of Hepatocellular Apoptosis
Fig. 2A shows representative confocal microscopy images 
of TUNEL (green fluorescence)-labeled hepatocytes. 
The apoptotic index in the dh404 group (2.1 ± 2.0) was 
significantly lower when compared to the control group 6.1 
± 5.9) (Figure 2B, P<0.05). 
ALT and MDA in the Serum, and MPO Activity 
and ADP/ATP Ratio in the Liver 
Serum ALT level in the dh404 treated rats (542±234 IU/
ml) was significantly lower compared to the untreated 
group (1794±680 IU/ml, P<0.005, Figure 3A). These 
findings may indicate that the liver experienced less 
damage from ischemic injury by dh404 administration.
   Serum MDA which is a marker of oxidative stress was 
significantly lower in the dh404 treated rats (23.9±3.8μM) 
compared to the untreated (31.5±4.1, p<0.05) group (Fig 
3B). Likewise, liver tissue MPO level in the dh404-treated 
group was significantly lower (9.9 ± 4.5 µM) compared to 
the untreated group (29.2± 6.1 µM, p<0.05) (Figure 3C).
These findings suggest that oxidative stress was reduced in 
the dh404-treated group. However, there was no significant 
difference in the ADP/ATP ratio between the two groups. 
Nrf2, Antioxidant and Inflammatory Mediators 
No significant difference was found in either the nuclear 
or cytoplasmic Nrf2 contents or expression of catalase, 
SOD, GPX, or eNOS between the two groups (Figure 
4, 5). Likewise no significant difference was found in 
expression of inflammatory factors including NF-ĸB, and 
Cox-2 between the two groups. However, GCLM and 
GCLC expressions were significantly increased in the 
dh404-treated group (Figure 4, 5).
DISCUSSIONS
IRI occurs during liver surgery including liver resection, 
transplantation and trauma. Oxidant stress plays a 
critical role in the ischemia–reperfusion-induced organ 
damage. IRI is largely due to the accumulation of ROS 
and oxidative degradation of lipids, proteins, and nucleic 
acids in the affected tissue. Nrf2 regulates the antioxidant 
response element (ARE) which controls the expression 
of numerous antioxidant and detoxifying enzymes and 
related proteins and plays a major role in defense against 
oxidative stress and inflammation.  Previous studies 
have shown that administration of dh404 derivatives 
confers cytoprotective effects in different organs and 
tissues by inducing activation of Nrf2 and upregulation of 
cytoprotective proteins[18-22]. However, the effect of dh404 
on hepatic IRI has not been defined. Given the critical 
role of oxidative stress in the pathogenesis of tissue injury 
in IRI and the central role of Nrf2 in host defense against 
oxidative stress, in this study, we investigated the effect of 
the Nrf2 inducer, dh404, in a rat model of hepatic IRI. The 
study revealed that the pretreatment with dh404 resulted 
in increased GCLM and GCLC expressions and modest 
reduction of hepatocyte damage.
Histological examination of the liver in the study 
animals revealed severe pathological alterations marked 
by sinusoidal congestion, necrosis, and severe endothelial 
injury and cytoplasmic vacuolization. Although severity 
of tissue damage in the dh404 treated rats was less than 
that found in the untreated animals using the unpaired 
t-test the difference did not reach statistical significance. 
However, semi-quantitative assessment of necrosis 
conducted according to the score system reported by 
Camino et al showed significant improvement in the 
dh404 treated group. In addition, serum ALT levels were 
significantly lower in the dh404 treated rats indicating 
a reduction in the intensity of liver damage in these 
animals. This was associated with a significant reduction 
of MDA levels pointing to attenuation of oxidative stress 
in the dh404-treated rats. 
IRI  resu l t s  in  acu te  in f lammatory  response 
characterized by accumulation of neutrophils which can 
intensify tissue damage by generating reactive oxygen 
and halogen species. In fact histological examination of 
tissues in the study animals revealed heavy accumulation 
of neutrophils in the liver which was confirmed by 
elevation of MPO activity. Pretreatment with dh404 
resulted in significant reduction of neutrophil infiltration 
and MPO activity in the liver pointing to attenuation of 
0
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Cytoplasmic Nrf2 
N.S. 
Nuclear Nrf2 
0
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1
1.5
2
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Fig.4 
Figure 4
Nrf2 Expression in Both Cytoplasm and Nucleus in 
the Liver
Note. The data were expressed as relative values standardized 
by GAPDH for cytoplasmic protein and histone for nucleus 
protein. There was no significant difference in Nrf2 expression 
in both cytoplasm and nucleus.
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the first time that pretreatment with Nrf2 inducer, 
dh404 confers partial protection against experimental 
hepatic IRI by attenuating oxidative stress and 
enhancing the antioxidant defense system.
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